News Archive
News from the medical and pharmaceutical industry
September 2002
|
-
ReGen Obtains Approval in Australia 2002-09-30
-
New Study Shows RegeneRx's TB4 Stimulates Migration and Production of Of Key Molecule Necessary for Eye Repair 2002-09-30
-
Imugene Signs Evaluation and Sublicense Option Contracts With Merial 2002-09-30
-
Ortec to Collaborate with HAPTO to Develop New Products and Technologies for Use in Tissue Regeneration and Repair 2002-09-30
-
Guidant Announces Preliminary Results of Large Drug Eluting Stent Trial 2002-09-30
-
Study Comparing Once-Daily Cipro XR to Conventional Twice-Daily Cipro Supports Safety and Efficacy of Cipro XR for the Treatment of Uncomplicated Urinary Tract Infections 2002-09-30
-
Eunoe Initiates Alzheimer's Disease Clinical Trial Site in Tucson; Neurological Associates of Tucson Begins Patient Enrollment 2002-09-30
-
ChromaVision and Ventana to Co-Market HPV Cervical Cancer Test 2002-09-30
-
NDC to develop a class of safe natural-occurring plant alkaloids and other nAChR agonist that stimulate adult stem cell recruitment for potential blockbuster nonprescription drugs 2002-09-30
-
Aurora Imaging Technology Announces MRI Guided Biopsy at Faulkner Hospital 2002-09-30
-
AVANT Announces Results of a Phase II Dose-Ranging Study with its Peru-15 Cholera Vaccine Candidate 2002-09-30
-
FDA approval of INJEX systems 2002-09-30
-
siRNA Kits Introduced by Imgenex 2002-09-30
-
Results from Comparative Study Show Fosamax-R- Increased BMD in the Hip and Spine More Than Actonel in Postmenopausal Women with Osteoporosis 2002-09-29
-
Phase III Study of Viread Shows Favorable Lipid and Mitochondrial DNA Profile in Treatment-naive HIV Patients (Gilead Sciences) 2002-09-27
-
R2 Technology, Inc., Files Patent Infringement Suit Against CADx Medical Systems, CADx Systems and Qualia Computing Corporations 2002-09-27
-
Studies Presented At Heart Failure Society Meeting Focus On Benefit of Vasomedical's EECP Therapy in Patients With Compromised Left Ventricular Function 2002-09-27
-
Researchers Report In Vitro Results of Advancis Pharmaceutical Corporation's Pulsatile Dosing of Antimicrobials 2002-09-27
-
Nonlinear Dynamics and Amersham Biosciences Announce Further Collaboration by Signing Exclusive Software Deal For ImageQuant TL 2002-09-27
-
Guidant Announces Results of Key Study In Emerging Field of Heart Attack Prevention; Vulnerable Plaque Presents Significant Opportunity for Preventive Therapy 2002-09-27
-
EFP Enters Nano-Technology Agreement 2002-09-27
-
B-K Medical A/S to Supply Dynamic Imaging Ltd. With High Quality Equipment for Veterinary Ultrasound Scanning 2002-09-27
-
FDA: MedWatch - new safety info on Prempro/Premphase and Premarin 2002-09-26
-
PamGene's Partner Olympus Launches FD10 Next-Generation DNA Microarray System 2002-09-26
-
Progenics Reports Positive Results of Completed Phase II Clinical Study of HIV Entry Inhibitor PRO 542; PRO 140 CCR5 Inhibitor on Target to Enter Clinic in 2003 2002-09-26
-
ReGen Biologics Announces Completion of CMI U.S. Clinical Trial Enrollment 2002-09-26
-
Medicis Announces License and Development Agreement with Dow Pharmaceutical Sciences 2002-09-26
-
PSS World Medical's Long-term Care Business Acquires Advantage Medical Products, LLC 2002-09-26
-
Variagenics Initiates Colorectal Cancer Diagnostics Program; Company's First Clinical Study to Identify Genetic Markers for Chemotherapeutic Toxicity 2002-09-26
-
Transition Therapeutics' I.N.T Treatment Stimulates Regeneration of Human Insulin-Producing Cells 2002-09-26
-
Geron Corporation Makes Embryonic Stem Cell Protocols Available 2002-09-26
-
Quinton Releases Compact, True 12 Lead Holter Recorder 2002-09-26
-
FeRx Regains Commercialization Rights to MTC-DOX in the U.S. and Europe; FeRx and Elan Corp. Mutually Agree to Terminate Joint Venture in Oncology 2002-09-26
-
Palatin Technologies Reports Phase 1 Data for PT-141: Palatin's Treatment for Sexual Dysfunction 2002-09-26
-
PointDx Licenses Virtual Endoscopy Technology to Siemens 2002-09-26
-
Medtronic Advances Technology for Coronary Angioplasty With Unique `Zipper' Multi-Exchange Delivery Platform 2002-09-26
-
Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion Article Attempts to Turn Back the Clock on Care of Severe Sepsis Patients 2002-09-26
-
IMPAX Comments on Purdue Pharma Lawsuit Related to Its Generic Version of OxyContin; Also Amends Filing to Include Additional Strengths 2002-09-26
-
Cell Pathways Receives Notice of Allowance for Broad Patent Applying Its Core Technology to the Treatment of Inflammatory Bowel Disease 2002-09-25
-
PharmQuest Announces Cooperative Agreement With FDA to Co-Develop a Carcinogenicity and Toxicology Data Management System 2002-09-25
-
Guidant Commends New Guideline for Defibrillator Implants; New Guideline Reflects Results of MADIT II Trial 2002-09-25
-
Genopsys Offers Royalty-Free Access to Proprietary Directed Evolution Tools for Developing Anti-Cancer Products 2002-09-25
-
PanaMed Corporation Concludes Stage One of Treatment Program for HIV/AIDS Therapeutic. Stage Two to Include Larger Patient Base 2002-09-25
-
Organogenesis Inc. Files for Chapter 11 Protection from Creditors 2002-09-25
-
Dyax Presents Interim Results From its Phase II DX-88 Clinical Trial for the Treatment of Hereditary Angioedema 2002-09-25
-
InSite Vision Reports Favorable Phase II Results With ISV-401 for Treating Bacterial Conjunctivitis; Company Plans to Enter Phase III Clinical Trials in Early 2003 2002-09-25
-
Ventana Acquires HPV Business Assets From Beckman Coulter Including Direct License From Institut Pasteur 2002-09-24
-
VIASYS Healthcare Inc. Begins Worldwide Shipment of the AVEA Ventilator 2002-09-24
-
Media Cybernetics Announces Acquisition of Definitive Imaging Assets 2002-09-24
-
Kaleidos Pharma, Inc. Announces Collaboration With the NIH to Investigate TGF-alpha for the Treatment of Parkinson's Disease 2002-09-24
-
Guidant Launches Next-Generation Radiotherapy System in the United States; System Designed to Enable Physicians to Treat Long Vessel Blockages With Ease and Precision 2002-09-24
-
Indevus Announces Positive Phase III Results With Trospium in Overactive Bladder 2002-09-24
-
Beckman Coulter to Offer Nanoliter Dispensing Capabilities; Miniaturization to Meet Demands of Drug Discovery, Proteomics and Genomics Markets 2002-09-24
-
Axonyx Acquires Technology to Identify New Agents to Inhibit Beta Amyloid in Alzheimer's Disease 2002-09-24
-
Fast Track Designation Approved by FDA for Aphton's G17DT Anti-Gastrin Immunogen for Pancreatic Cancer Therapy 2002-09-24
-
Complete Phase 2A Data Presented For PT-141: Palatin's Treatment For Male Erectile Dysfunction 2002-09-24
-
Quinton Begins Shipment of 608 MHz Cardiac Rehabilitation Telemetry System 2002-09-23
-
Serologicals Announces Recruitment of Plasma Donors To Help Prepare Nation for Possible Smallpox Attacks 2002-09-23
-
MedPointe Completes Sale of Wampole Laboratories; Inverness Medical Innovations Acquires Diagnostics Business 2002-09-23
-
Dolphin Medical, Inc. and QRS Diagnostic Enter Into Strategic Alliance; Medical Device Companies Protect Patents and Cross License Technologies 2002-09-23
-
BD Bifurcated Needle Launched for Smallpox Vaccination Efforts; Specialized Needle is Manufactured for International Biodefense Programs 2002-09-23
-
Synthetic Blood International Announces Successful Completion of Key Animal Studies 2002-09-23
-
FeRx Reports Results On Magnetically Targeted FUDR as Potential Means of Treating Colon Lesions 2002-09-23
-
Newly Published Study Shows Coblation Tonsillectomy to be Less Painful, Fast-Healing Procedure 2002-09-23
-
ARIAD Reports In Vivo Efficacy of First-in-Class Product Candidates to Treat the Spread of Cancer to Bone and Osteoporosis 2002-09-23
-
Cytomedix, Inc. Announces Definitive License Agreement for AutoloGel With Providence Home Care, LLC 2002-09-23
-
Guidant Introduces Innovative New Device for Coronary Bypass Graft Procedures; New Technology May Reduce Risk of Major Complications 2002-09-23
-
FDA: Portal Page Debuts With Information for FDA-Regulated Industry 2002-09-23
-
FDA: Research Shows Improved Food Handling by Consumers 2002-09-23
-
Amersham Biosciences Introduces LEADseeker Multimodality Imaging System 2002-09-23
-
Quinton Receives Frost & Sullivan Market Engineering Leadership Award 2002-09-23
-
OSI Pharmaceuticals Receives Second FDA Fast-track Designation for Tarceva; Announces Amendments to Tarceva Development Plan 2002-09-23
-
New Titan Penile Implant Designed for Men With Drug Resistant Erectile Dysfunction 2002-09-23
-
Amersham Biosciences Partners with Imaging Research Inc. to Co-develop IN Cell Analyzer 1000 2002-09-23
-
Amersham Biosciences Launches IN Cell Analyzer 3000; High-Throughput Imaging System Enables Direct Analysis of Drug Activity at the Cellular Level 2002-09-23
-
Fujisawa Pharmaceutical Enters Research Agreement With Pharmagenesis; Two Companies Will Collaborate to Develop Drugs Based on Chinese Herbs 2002-09-23
-
Progenics and Cytogen Report Positive Preclinical Results for Experimental Prostate Cancer Drug 2002-09-23
-
FDA Approves Gilead's Hepsera for the Treatment of Chronic Hepatitis B 2002-09-20
-
Vapotherm, Inc. announces multi-year exclusive distribution agreement with Profile Respiratory Systems, Ltd. of the United Kingdom 2002-09-20
-
Gretag Imaging AG and Applied Science Fiction(TM) Announce their Intent to Test Market the Modular Digital PIC(TM) Dry Film Processing Solution 2002-09-20
-
Transition Therapeutics Inc. Receives Approval to Initiate Phase I Clinical Trial for Islet Neogenesis Therapy 2002-09-20
-
Lilly and Amylin To Collaborate on Potential Breakthrough Diabetes Treatment 2002-09-20
-
Cardima Submits PMA Application to FDA for Approval of REVELATION Tx for Treatment of Atrial Fibrillation 2002-09-20
-
FDA Approves Cozaar to Reduce the Rate of Progression of Nephropathy in Type 2 Diabetic Patients with Nephropathy and Hypertension 2002-09-20
-
FDA: Panel Will Discuss Safety of Acetaminophen, Other OTC Pain Relievers 2002-09-20
-
PerkinElmer Launches Three New Drug Discovery Reagent Platforms 2002-09-19
-
Endovasc Spins Off a Potential Blockbuster Anti-Inflammatory/Cardiovascular Drug 2002-09-19
-
Hemedex, Inc. Announces Alliance With The Anspach Effort, Inc. to Market Its Tissue Perfusion Monitor 2002-09-19
-
Norwood Abbey Obtains Patent for Laser-Assisted Pharmaceutical Delivery and Fluid Removal 2002-09-19
-
Society of Laparoendoscopic Surgeons -- SLS - Taps Karl Storz, Image 1 Digital Camera Technology for `Innovations of the Year' Award 2002-09-19
-
Illumina to Conduct Large-Scale SNP Genotyping Services for GlaxoSmithKline 2002-09-19
-
LScan Announces Successful Launch of SampLScan a Sample Management and Compliance Solution for the Pharmaceutical Industry 2002-09-19
-
Alliance Pharmaceutical Corp. to Work with Baxter to Explore Avenues to Preserve PFC Therapeutics 2002-09-18
-
Applied Biosystems Introduces New Chemistries to Increase the Productivity of Sequencing 2002-09-18
-
InforMax, Inc. is introducing Vector NTI Advance(TM). 2002-09-18
-
Oridion BreathID Breath Testing System Shown to be Improved Method for Measuring Gastric Emptying Rate -GER- 2002-09-18
-
Bioheart Receives FDA Authorization to Initiate Myocell Studies in the USA and Receives ISO 9001 Certification for Myocath Production Facility 2002-09-18
-
Hi-Tech Pharmacal Receives FDA Approval for Timolol Maleate Opthalmic Solution 0.5 2002-09-18
-
Acusphere Receives U.S. Patent for Sustained Release Porous Microparticle Formulations; Asthma Drug, AI-SR, in Clinic Using Patented Technology 2002-09-18
-
Fischer Imaging Partners With R2 Technology to Develop and Market Advanced CAD Software for the SenoScan System to Aid in the Earlier Detection of Breast Cancer 2002-09-17
-
Maxim Announces Initiation of Enrollment in Radiation Dermatitis Clinical Study 2002-09-17
-
Large Scale Biology Corporation Files for Orphan Drug Status on Plant-Produced Human Alpha-Galactosidase A 2002-09-17
-
BioSyntech Inc.: A Novel Non-Toxic Sustained Release Taxol Formulation for Cancer Chemotherapy 2002-09-17
-
ARIAD Announces Agreement On Human Embryonic Stem Cells With University of Wisconsin's WiCell Research Institute 2002-09-17
-
Matritech Selects Cytogen to Market and Distribute New Point-of-Care Diagnostic Test for Bladder Cancer in U.S. 2002-09-17
-
Lilly Launches Large Severe Sepsis Clinical Trial; 11,000 Patients to be Enrolled in Study of Xigris Use in Patients with Low Risk of Death 2002-09-17
-
Anesoft Announces Bioterrorism Simulator 2002-09-17
-
Hydro Med Sciences Initiates Clinical Development of a Long-Duration Hormonal Therapy for Central Precocious Puberty 2002-09-17
-
Molecular Diagnostics Inc. Enters Strategic Agreement with Perceptronix Medical Inc. 2002-09-17
-
MagneVu, Diagnostic Imaging Announce Distribution Agreement 2002-09-17
-
Genentech and Xoma Announce Phase III Study With Raptiva Achieves Primary Efficacy Endpoint 2002-09-17
-
ChemoCentryx Announces Initiation of Phase I Clinical Trial of T487 by Tularik 2002-09-17
-
Endovasc Ltd., Inc.: New Subsidiary Announced by Biotech Company with the only Angiogenesis Drug Approved for FDA Phase III Human Clinical Trials 2002-09-17
-
North American Scientific Provides Guidance on Timing of Completion of Investigational New Drug Submission for Hynic-Annexin V 2002-09-17
-
DRAXIS Accepted by FDA to Manufacture Solid Dosage Form Products 2002-09-17
-
Silimed Corporation Silicone Implants are Back With FDA Approval 2002-09-16
-
Nymox NicAlert Used in National Stop-Smoking Campaign in Switzerland 2002-09-16
-
Applied Molecular Evolution Signs Kauffman Licensing Agreement with NascaCell 2002-09-16
-
Guidant Launches Newest Coronary Stent in the United States 2002-09-16
-
FDA Issues Approvable Letter for Lilly's Cymbalta for Treatment of Depression 2002-09-16
-
Axya Medical Announces 510 k Clearance for its Sonic Scalpel 2002-09-16
-
New Study on ARIAD's Cell-Signaling Regulation Technology Highlights Breakthrough in Stem Cell Therapy 2002-09-16
-
Meditech Signs Memorandum of Understanding with P&P Research of Seoul, Korea 2002-09-16
-
Epicyte Partners with aaiPharma to Develop Industry's First Topical Mononclonal Antibody 2002-09-16
-
FDA: Website Offers Information on Analgesics and Anti-Inflammatory Drugs 2002-09-16
-
FDA's Plans for Implementing Bioterrorism Law Explained on New Website 2002-09-16
-
FDA: Health Advisory Issued About Increased Listeria Cases in Pennsylvania 2002-09-16
-
FDA: Draft Guidance Issued to Evaluate Safety of New Antimicrobial Animal Drugs 2002-09-16
-
FDA: Five Kidney Dialysis Deaths Possibly Linked to Blood Tubing 2002-09-16
-
Stand-Up MRI of Islandia Receives ACR Accreditation; Facility Managed by FONAR Subsidiary HMCA 2002-09-15
-
Stanford Researchers Devise Novel Gene Therapy Technique 2002-09-15
-
Immune Network and Jacobus Sign Letter of Intent for Dapsone License 2002-09-13
-
World Diagnostics, Inc. Issues Rectification of August 7, 2002 Press Release, Regarding Smart Check Malaria 2002-09-13
-
Organogenesis Temporarily Halts Shipments of Apligraf; Discussions with Novartis Are Continuing 2002-09-13
-
Immune Network Locks Alzheimer Trial Database and Forms Clinical Advisory Team 2002-09-12
-
Geron Corporation Reports Publication of Research Validating Telomerase Cancer Immunotherapy 2002-09-12
-
Vasomedical's EECP Therapy Shown to Produce Improvement in Functional Status Similar to That Seen in Patients One Year After Bypass Surgery 2002-09-12
-
Judge Grants Teva Summary Judgment of Invalidity for Patent Related to Hydrocodone Bitartrate and Ibuprofen Tablets 2002-09-12
-
CytoGenix Inc. Starts Pre-clinical Trials of Herpes Simplex Anti-viral 2002-09-12
-
Corixa Technology May Be Useful for Testing U.S. Blood Supply for Presence of Deadly Parasite 2002-09-12
-
Andrx Receives FDA Approval on Additional Indication for Altocor 2002-09-12
-
Equidyne Corp. Receives FDA Approval for OTC Marketing of the INJEX 30 System for Insulin 2002-09-12
-
Biolex Inc. And Debiopharm S.A. Sign Collaboration 2002-09-12
-
PharmaNetics Completes Enrollment of 600-Patient Elect Trial; ENOX Results To Be Presented At American Heart Association Meeting 2002-09-12
-
Teva Announces Final Approval of Nizatidine Capsules 2002-09-12
-
International Trial Evaluating Tarceva In Lung Cancer Completes Patient Enrollment 2002-09-11
-
Philips to Sell Healthcare Products Group to Platinum Equity 2002-09-11
-
One-Year Anniversary of AbioCor Patient to be Celebrated September 13 2002-09-11
-
Central Venous Catheters Benefit From Carmeda Surface Coating After 30 Days According to Recently Published In-Vivo Data 2002-09-10
-
Hollis-Eden Announces Publication of Results Showing Benefit of Immune Regulating Hormone Therapy in Preclinical Model of Multiple Sclerosis 2002-09-10
-
BD Medical and Luther Research Partners Sign Multi-Patent License Agreement 2002-09-10
-
Cypress Completes Enrollment of Phase II Milnacipran Clinical Trial; Results Expected in Early 2003 2002-09-10
-
SinusPharma Launches New Subsidiary: SinusPharmaceuticals Research 2002-09-10
-
Innercool Initiates Acute Myocardial Infarction Clinical Trial 2002-09-10
-
Ionix Intranasal Opioid Analgesic Starts Phase I Trial 2002-09-10
-
Nutrition 21 Initiates Diachrome Clinical Study to Evaluate Improvement in Blood Sugar Control in Children and Adults with Type 2 Diabetes 2002-09-10
-
Senesco Technologies' Factor 5A Gene Induces Apoptosis in Human Cancer Cells 2002-09-10
-
Insmed Discontinues Internal Development of INS-1 for Diabetes and Polycystic Ovary Syndrome - PCOS - 2002-09-10
-
Maxim Advances Enrollment of Ceplene Phase 2 Clinical Trial in Hepatitis C Nonresponder Patients 2002-09-09
-
Eon Labs Announces Trial Cancelled in Cyclosporine Lawsuit 2002-09-09
-
Phase III Trial With Avastin in Relapsed Metastatic Breast Cancer Does Not Meet Primary Endpoint 2002-09-09
-
BIOTRONIK Announces FDA Approval of the Tachos DR-Atrial Tx Implantable Cardioverter Defibrillator 2002-09-09
-
Maxxon, Inc. requests an extension of time to file the revised 510(k) application for its 12cc safety syringe. 2002-09-09
-
EPMedSystems Receives Equity Investment From Boston Scientific 2002-09-09
-
Cubist and Gilead End European Commercialization Agreement for Investigational Antibiotic CIDECIN 2002-09-09
-
License Granted in Canada for New Biomarker Test; Early, Accurate Diagnosis Of Cardiac Conditions 2002-09-09
-
Microvision Signs Feasibility Agreement with Johnson & Johnson's Ethicon Endo-Surgery Unit 2002-09-09
-
ANS Announces 1,000th Implant of Genesis Spinal Cord Stimulator 2002-09-09
-
Microtek Unveils Triple-Interface Large-Format ScanMaker(TM) 9800XL 2002-09-09
-
Valley Forge Scientific Signs Development Agreement With Stryker 2002-09-09
-
Great Smokies Diagnostic Laboratory Announces New Addition to Growing Line Of Predictive Genomic Profiles 2002-09-09
-
AST Products, Inc. Forms a Licensing Agreement with Occam International BV 2002-09-09
-
Guidant Announces Completion of Patient Enrollment for Key Study of Heart Attack Prevention 2002-09-09
-
ImageGuide, Inc. to Advance Image-Guided Robotic Surgery 2002-09-09
-
AlphaRX Announces Data and Comparative Results on ARX2002 Non-Steroidal Anti-inflammatory Compound and Continued Pre-Clinical Development in Neuroprotective Applications. 2002-09-09
-
FDA to Merge Review of Drugs and Biological Pharmaceuticals 2002-09-06
-
Genentech Wins Patent Dispute with Chiron 2002-09-06
-
MDA - Ambulance Stretcher Trolleys : Ferno Falcon Mk2, Mk3 and Hawk models: Risk of leg post fracture 2002-09-05
-
Ixion Initiates Treatment in German Pilot Clinical Trial 2002-09-05
-
Teva Announces Approval of Cefaclor ER Tablets 2002-09-05
-
Progen's US Cancer Drug Trial Progresses 2002-09-05
-
Cubist Pharmaceuticals Announces Enrollment of First Patients in Phase III CIDECIN Endocarditis/Bacteremia Trial 2002-09-05
-
Cypress Bioscience Inc. Establishes Collaboration with Collegium Pharmaceutical Inc. to Develop Second Generation Milnacipran 2002-09-05
-
Ligand's Targretin Gel Shows Promise for Many Chronic Severe Hand Dermatitis Patients 2002-09-05
-
Cook Wins Approval To Sell Second Paclitaxel-Eluting Stent In Europe 2002-09-05
-
NorStar Group Inc. To Acquire Receptogen, Inc. 2002-09-05
-
Diacrin Licenses its Muscle Cell Transplantation Technology for Cardiac Disease to Terumo for Japan 2002-09-05
-
Kirin Advances Dendreon's Mylovenge Vaccine into Phase II Studies in Japan 2002-09-05
-
Miravant Receives U.S. Patent for Highly Potent Classes of Light Activated Drugs; Patent Covers Dermatology Drug MV9411 Now in Phase II Clinical Trials for Psoriasis 2002-09-05
-
ARIAD Announces New Clinical-Scale Production Methods for Its Graft-vs-Host Disease Product Candidate 2002-09-05
-
EPMedsystems and Premier Sign Purchase Agreement 2002-09-04
-
Immuno-Designed Molecules Obtains a Patent in the USA That Protects Its Therapeutic Approach to Dendritic Cell Based Anti-Cancer Vaccines 2002-09-04
-
Central Vacuum System Use Eases Allergy Suffering 2002-09-04
-
Orqis Medical Begins European Clinical Trial for its Cancion Cardiac Recovery System - CRS 2002-09-04
-
Seattle Genetics Reports Findings From SGN-30 Phase I Clinical Study 2002-09-04
-
Charles River Introduces 'In Vitro' Test Product For the Detection of Harmful Contaminants in Drugs 2002-09-04
-
Vitalstate, Inc. Signs Manufacturing Agreement With Confab Laboratories 2002-09-04
-
PharmaNetics Signs Agreement with the Medicines Company; Company to Obtain Data Required for Regulatory Clearance of Ecarin Clotting Time Test, ECT 2002-09-04
-
Peoples Genetics Deploys High-Throughput Capacity for DNA Analysis in Large Populations; New Instruments Speed Analysis of 2 Million Person-Genes 2002-09-04
-
Elan Announces Approval of New Versions of Skelaxin and tizanidine 2002-09-04
-
Medical Action Industries Agrees to Acquire BioSafety Division of Maxxim Medical, Inc. 2002-09-04
-
Horizon Medical Sells Stepic to Arrow International 2002-09-03
-
Hitachi Medical Corporation Consolidates Diagnostic Imaging Equipment in the United States 2002-09-03
-
Cardiome Drug Effective for Heart Patients 2002-09-03
-
Biophan Technologies to Begin Animal Testing of MRI-Safe Pacemaker 2002-09-03
-
B. Braun Horizon Outlook IV Safety Infusion System Is First To Address Proposed FDA Bar Code Requirements 2002-09-03
-
AVANT Appoints Lohmann as Exclusive Distributor of its Poultry Vaccines 2002-09-03
-
IMPAX Receives FDA Approval for Generic Flumadine 2002-09-03
-
Neurosciences Advanced Imaging Research Center Opens to Develop Early Detection of Alzheimer's Disease 2002-09-03
-
PSS World Medical's Physician Business Enters Into Exclusive Distribution Agreement With Beckman Coulter, Inc. for Diagnostic Chemistry Products 2002-09-03
-
Esoterix Introduces CenterlinX for Clinical Trials Data Management 2002-09-03
-
Fentanyl for Treating Breakthrough Cancer Pain 2002-09-03
-
Interleukin Genetics Signs Letter of Intent to Enter Into Product Development and Distribution Alliance 2002-09-03
-
IVAX Consolidates Manufacturing Facilities In Argentina 2002-09-03
-
Geron Demonstrates Differentiation of Cardiomyocytes From Human Embryonic Stem Cells 2002-09-03
-
Applied Biosystems Enhances the QSTAR LC/MS/MS System With Improved Performance and Increased Mass Range 2002-09-03
-
FDA: Foods Center Announces New System for Tracking Adverse Events 2002-09-03
-
FDA: Contaminated Honey Import Scheme Uncovered 2002-09-03
-
FDA: Abbott Laboratories Gonorrhea Test Kits Recalled After Being Shown to be Unreliable 2002-09-03
-
FDA Approves Watch-Like Device to Monitor Glucose in Diabetic Children 2002-09-03
-
MDA - Ten good-practice points for the use of benchtop steam sterilizers 2002-09-02
-
OXiGENE's Second-Generation Vascular Targeting Compound Demonstrates Potent Tumor-Killing Activity 2002-09-02
-
Results of Trial with COZAAR in Patients with Acute Myocardial Infarction Presented at European Society of Cardiology 2002-09-02
-
Lilly and EFSD Announce a EUR 2 Million Partnership for Diabetes Research; New European Program is Entitled EFSD-Lilly Research Fund 2002-09-02
|
|